These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3315267)

  • 21. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
    Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
    Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.
    D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger H; Steinijans VW
    Am Rev Respir Dis; 1990 Jul; 142(1):84-90. PubMed ID: 2195936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of nocturnal asthma in children with a single dose of sustained-release theophylline taken after supper.
    Pedersen S
    Clin Allergy; 1985 Jan; 15(1):79-85. PubMed ID: 3884180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical use of controlled-release theophylline in chronic airways obstruction.
    Dal Negro R; Turco P; Pomari C; Cordaro CI
    J Int Med Res; 1987; 15(6):391-6. PubMed ID: 3436486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of withdrawal of sustained-release theophylline in patients with chronic obstructive lung disease.
    Aamodt T; Dahle R; Horgen O
    Allergy; 1988 Aug; 43(6):411-4. PubMed ID: 3189721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1982 Apr; 13(4):569-71. PubMed ID: 7066172
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronopharmacodynamics and kinetics after symmetric and asymmetric multiple theophylline doses in patients with chronic obstructive pulmonary disease.
    Gimeno F; van Veenen R; Berg WC; Steenhuis EJ; Jonkman JH; Weibel MA
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):7-12. PubMed ID: 2744908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.
    Lamont H; Pauwels R; Van der Straeten M
    Br J Clin Pharmacol; 1987 Dec; 24(6):735-42. PubMed ID: 3440095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of plasma levels of 2 delayed-action theophyllines: Theostat 200 and Theodur 200, after a single evening dose].
    Philip-Joet F; Bruguerolle B; Lagier F; Arnaud A
    Rev Pneumol Clin; 1986; 42(6):279-83. PubMed ID: 3563255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of sustained-release theophylline ('Theo-dur') for the treatment of chronic reversible obstructive lung disease in hospital practice.
    Riddington CJ; Shipman AJ
    Br J Clin Pract; 1985 Apr; 39(4):148-53. PubMed ID: 3893504
    [No Abstract]   [Full Text] [Related]  

  • 32. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
    Bachmann K; Jauregui L; Sides G; Sullivan TJ
    J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a sustained-release theophylline tablet in young asthmatics.
    Swigart SA; Kobayashi RH; Baldwin JN
    J Asthma; 1985; 22(4):195-202. PubMed ID: 4044473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
    Murciano D; Auclair MH; Pariente R; Aubier M
    N Engl J Med; 1989 Jun; 320(23):1521-5. PubMed ID: 2498658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of theophylline on cortisol plasma concentrations in patients with chronic obstructive pulmonary disease.
    Gimeno F; Steenhuis EJ; Jonkman JH
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):139-43. PubMed ID: 2187001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained release theophylline in nocturnal asthma.
    Elias-Jones AC; Higenbottam TW; Barnes ND; Godden DJ
    Arch Dis Child; 1984 Dec; 59(12):1159-61. PubMed ID: 6395810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of theophylline on lung function and sleep in patients with severe chronic obstructive pulmonary disease].
    Li Y; Liu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):294-8. PubMed ID: 10374456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter comparison of once-daily Uniphyl tablets administered in the morning or evening with baseline twice-daily theophylline therapy in patients with nocturnal asthma.
    Grossman J
    Am J Med; 1988 Jul; 85(1B):11-3. PubMed ID: 3041821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overnight theophylline concentrations and effects on sleep and lung function in chronic obstructive pulmonary disease.
    Martin RJ; Pak J
    Am Rev Respir Dis; 1992 Mar; 145(3):540-4. PubMed ID: 1546832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.